Small bugs, big business: The economic power of the microbe

被引:126
作者
Demain, AL [1 ]
机构
[1] MIT, Dept Biol 68 223, Fermentat Microbiol Lab, Cambridge, MA 02139 USA
关键词
biotechnology; primary metabolites; secondary metabolites; economics;
D O I
10.1016/S0734-9750(00)00049-5
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The versatility of microbial biosynthesis is enormous. The most industrially important primary metabolites are the amino acids, nucleotides, vitamins, solvents, and organic acids. Millions of tons of amino acids are produced each year with a total multibillion dollar market. Many synthetic vitamin production processes are being replaced by microbial fermentations. In addition to the multiple reaction sequences of fermentations, microorganisms are extremely useful in carrying out biotransformation processes. These are becoming essential to the fine chemical industry in the production of single-isomer intermediates. Microbially produced secondary metabolites are extremely important to our health and nutrition. As a group, they have tremendous economic importance. The antibiotic market amounts to almost 30 billion dollars and includes about 160 antibiotics and derivatives such as the beta-Iactam peptide antibiotics, the macrolide polyketide erythromycin, tetracyclines, aminoglycosides and others. Other important pharmaceutical products produced by microrganisms are hypocholesterolemic agents, enzyme inhibitors, immunosuppressants and antitumor compounds, some having markets of over 1 billion dollars per year. Agriculturally important secondary metabolites include coccidiostats, animal growth promotants, antihelmintics and biopesticides. The modern biotechnology industry has made a major impact in the business world, biopharmaceuticals (recombinant protein drugs, vaccines and monoclonal antibodies) having a market of 15 billion dollars. Recombinant DNA technology has also produced a revolution in agriculture and has markedly increased markets for microbial enzymes. Molecular manipulations have been added to mutational techniques as means of increasing titers and yields of microbial procresses and in discovery of new drugs. Today, microbiology is a major participant in global industry. The best is yet to come as microbes move into the environmental and energy sectors. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:499 / 514
页数:16
相关论文
共 75 条
[11]   RIBOFLAVIN OVERSYNTHESIS [J].
DEMAIN, AL .
ANNUAL REVIEW OF MICROBIOLOGY, 1972, 26 :369-&
[12]  
Demain AL, 1995, Actinomycetol, V9, P98, DOI 10.3209/ saj.9_98
[13]  
DEMAIN AL, 1978, ECON MICROBIOL, V2, P187
[14]  
Demain Arnold L., 1996, P233
[15]   A 2ND BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE GENE-CLUSTER (BKDFGH) FROM STREPTOMYCES-AVERMITILIS - ITS RELATIONSHIP TO AVERMECTIN BIOSYNTHESIS AND THE CONSTRUCTION OF A BKDF MUTANT SUITABLE FOR THE PRODUCTION OF NOVEL ANTIPARASITIC AVERMECTINS [J].
DENOYA, CD ;
FEDECHKO, RW ;
HAFNER, EW ;
MCARTHUR, HAI ;
MORGENSTERN, MR ;
SKINNER, DD ;
STUTZMANENGWALL, K ;
WAX, RG ;
WERNAU, WC .
JOURNAL OF BACTERIOLOGY, 1995, 177 (12) :3504-3511
[16]   L-Glutamate and L-lysine: traditional products wiU1 impetuous developments [J].
Eggeling, L ;
Sahm, H .
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 1999, 52 (02) :146-153
[18]   PRODUCTION OF A HYBRID MACROLIDE ANTIBIOTIC IN STREPTOMYCES-AMBOFACIENS AND STREPTOMYCES-LIVIDANS BY INTRODUCTION OF A CLONED CARBOMYCIN BIOSYNTHETIC GENE FROM STREPTOMYCES-THERMOTOLERANS [J].
EPP, JK ;
HUBER, MLB ;
TURNER, JR ;
GOODSON, T ;
SCHONER, BE .
GENE, 1989, 85 (02) :293-301
[19]  
ERNST, 1999, ERNST YOUNG 14 ANN R
[20]   CLONING OF THE MEMBRANE-BOUND ALDEHYDE DEHYDROGENASE GENE OF ACETOBACTER-POLYOXOGENES AND IMPROVEMENT OF ACETIC-ACID PRODUCTION BY USE OF THE CLONED GENE [J].
FUKAYA, M ;
TAYAMA, K ;
TAMAKI, T ;
TAGAMI, H ;
OKUMURA, H ;
KAWAMURA, Y ;
BEPPU, T .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1989, 55 (01) :171-176